US HB6109 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 6-0)
Status: Introduced on October 26 2023 - 25% progression
Action: 2024-12-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 26 2023 - 25% progression
Action: 2024-12-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.
Title
PILLS Act Producing Incentives for Long-term production of Lifesaving Supply of Medicine Act
Sponsors
| Rep. Claudia Tenney [R-NY] | Rep. Nicole Malliotakis [R-NY] | Rep. Carol Miller [R-WV] | Rep. Greg Murphy [R-NC] |
| Rep. Greg Steube [R-FL] | Rep. Mike Kelly [R-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-12-17 | House | Referred to the Subcommittee on Health. |
| 2023-10-26 | House | Referred to the House Committee on Ways and Means. |
| 2023-10-26 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/6109/all-info |
| Text | https://www.congress.gov/118/bills/hr6109/BILLS-118hr6109ih.pdf |
